Michael J. Cork

22.9k citations

211 papers · 8.6k indexed · 7 hit papers · h-index 49

Impact in

Dermatology top 0.01%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Immunology and Allergy top 0.05%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research

Papers in

Dermatology 163
- Dermatology and Skin Diseases 159
- Contact Dermatitis and Allergies 27
Immunology and Allergy 90
- Allergic Rhinitis and Sensitization 78
- Food Allergy and Anaphylaxis Research 30

Co-authors: Simon G. Danby Ulrich R. Hengge Thomas Ruzicka Robert A. Schwartz Rachid Tazi‐Ahnini Gordon W. Duff Yiannis Vasilopoulos A.J.G. McDonagh
Journals: British Journal of Dermatology (30 papers)Journal of the American Academy of Dermatology (18 papers)Journal of Investigative Dermatology (12 papers)Journal of Dermatological Treatment (9 papers)Journal of the European Academy of Dermatology and Venereology (7 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Michael J. Cork

200 papers receiving 8.2k citations

Hit Papers

7 papers align trajectories log scale

Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis 2023 · 80 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 JAMA Dermatology
2022 SHILAP Revista de lepidopterología
2020 The Lancet
2017 British Journal of Dermatology
2014 Journal of Allergy and Clinical Immunology
2009 Journal of Investigative Dermatology
2005 Journal of the American Academy of Dermatology

Peers

Countries citing papers authored by Michael J. Cork

Since Specialization

Citations

This map shows the geographic impact of Michael J. Cork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Cork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Cork more than expected).

Fields of papers citing papers by Michael J. Cork

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Cork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Cork. The network helps show where Michael J. Cork may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Cork, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Cork Line = papers co-authored together Michael J. Cork links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age The Journal of Allergy and Clinical Immunology In Practice ·Michael J. Cork, Mette Deleuran, Bob Geng, Jonathan I. Silverberg, Eric L. Simpson, Linda Stein Gold, Alan D. Irvine, William Romero, Hernán Valdez, Haiyun Fan, Jean-Phillippe Proulx-Gauthier	2025	3
2	Growth Analysis in Children Aged 6 to 11 Years and Adolescents Aged 12 to 17 Years With Moderate-To-Severe Atopic Dermatitis and Impact of 16 Weeks of Dupilumab Treatment on Height Journal of Allergy and Clinical Immunology ·Alan D. Irvine, Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Lisa A. Beck, Zhen Chen, C. Peralta, Zamiatina Mp, Akira Ikeuti, Sonya Cyr	2025	2
3	Management of Mild‐to‐Moderate Atopic Dermatitis With Topical Treatments by Dermatologists: A Questionnaire‐Based Study JEADV Clinical Practice ·Lawrence F. Eichenfield, Linda Stein Gold, Adelaide A. Hebert, Lyn Guenther, 克政乗松, Dan Ben‐Amitai, Roni P. Dodiuk‐Gad, Michael J. Cork, Valéria Aoki, Chia‐Yu Chu, Jianzhong Zhang, Lin Ma, Hidehisa Saeki, Paula Carolina Luna, Mark Jean Aan Koh	2025	0
4	Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis Dermatology and Therapy ·N. Micklem, Marta W. Turkiewicz, Katherine Vivivana Criollo Segura, Kirsty Brown, John Chittock, Linda J. Kay, Michael J. Cork, Simon G. Danby	2024	10
5	Novel biophysical skin biomarkers discriminate topical anti‐inflammatory treatments based on their potential for local adverse effects SHILAP Revista de lepidopterología ·Simon G. Danby, Stephen J. Matcher, Florian Kibler, H J Selle, L Fredenhagen, N. Micklem, Kirsty Brown, Linda J. Kay, Minoru Ohta, Fitrianingsih Aryanti, John Chittock, J. Arcamone, Amy Cha, Keduriia Kl, Chuanbo Zang, John L. Werth, Michael J. Cork	2024	0
6	Dupilumab treatment in children aged 6–11 years with severe atopic dermatitis is associated with reductions in serum immunoglobulin E and thymus and activation-regulated chemokine levels Revue française d'allergologie ·Michael J. Cork, Mieczysław Okupski, Franz Dienemann, Progress Mulenga, Simon R. Pitt, Najat Amharar, 野津征一郎	2023	1
7	The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial SKIN The Journal of Cutaneous Medicine ·Amy S. Paller, Jonathan I. Silverberg, Leidy Guante Henriquez, Michael J. Cork, L. Puig, Woburn St, Azra Kurbasic, QU Yan-ping, Eric L. Simpson	2023	1
8	Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial British Journal of Dermatology ·Stephan Weidinger, Thomas Bieber, Michael J. Cork, Adam Reich, Rosamund Wilson, Sonia Quaratino, Marisa Stebegg, Chris Curtin, Y. B. Chen, John T. O’Malley, Павло Дячук	2023	61
9	Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis Revue française d'allergologie ·Franz Dienemann, Michael J. Cork, Júlia Cabral Rinaldi, Mette Deleuran, China Data Lab, F.B. Hutt, Chih-Hung Su, Viktoriia Kyrychenko, G. L. Waxler, I. Martín Fragueiro	2023	1
10	Tolérance et efficacité à long terme du tralokinumab chez des adolescents atteints de dermatite atopique modérée à sévère : analyse intermédiaire d’ECZTEND A. Khemis, Eric L. Simpson, Andreas Wollenberg, Anthony Bewley, Michael J. Cork, Yongky Setiawan, Weily Soong, Peter Almgren, Le Gjerum, Warren E. Rose, Amy S. Paller, Herbert Atc	2023	0
11	P81 Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND British Journal of Dermatology ·Amy S. Paller, Michael J. Cork, Carsten Flohr, Christine Bangert, Stephan Weidinger, Philipp Hansen, 石与丹, Pinaki Biswas, Emory R. Johnson, Herwig Koppensteiner	2023	1
12	Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis Clinical and Experimental Dermatology ·Simon G. Danby, N. Micklem, H J Selle, Linda J. Kay, John Chittock, Marta W. Turkiewicz, Priscila Maria Santos Lima, Joyce Tunglut, Leonardo Rocha SANTOS, Tina Holm, Michael J. Cork	2022	35
13	Real-Time Infrared Spectroscopic Measurement of Natural Moisturizing Factor Journal of Investigative Dermatology ·John Chittock, Michael J. Cork, Simon G. Danby	2022	3
14	Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone skin* British Journal of Dermatology ·Simon G. Danby, N. Micklem, Linda J. Kay, Marta W. Turkiewicz, John Chittock, Kirsty Brown, Klára Szalay, Michael J. Cork	2021	44
15	Randomized controlled pilot trial with ion‐exchange water softeners to prevent eczema (SOFTER trial) Clinical & Experimental Allergy ·Zarif K. Jabbar‐Lopez, Laura Thum, Annette Briley, Danielle Greenblatt, Bu Yunfei, Joanne R Chalmers, Kim S Thomas, Kenneth W Snodgrass, (unknown), John Common, Simon G. Danby, Michael J. Cork, Janet L. Peacock, Carsten Flohr	2021	8
16	Vehicles for atopic dermatitis therapies: more than just a placebo Journal of Dermatological Treatment ·Simon G. Danby, Zoé Kececioglu Draelos, Linda Stein Gold, Amy Cha, Bonnie Vlahos, Gülsüm Arikan, Paul W. Sanders, Erik Grigg, Michael J. Cork	2020	36
17	An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1 Dermatology and Therapy ·Simon G. Danby, N. Micklem, Kirsty Brown, John Chittock, Linda J. Kay, Michael J. Cork	2020	25
18	The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta‐analysis Clinical & Experimental Allergy ·Zarif K. Jabbar‐Lopez, Chuin Ying Ung, Helen Alexander, Bu Yunfei, Joanne R Chalmers, Simon G. Danby, Michael J. Cork, Janet L. Peacock, Carsten Flohr	2020	19
19	Atopic dermatitis: a candidate for disease‐modifying strategy Allergy ·Thomas Bieber, Michael J. Cork, Sakari Reitamo	2012	94
20	The role of Staphylococcus aureus in atopic eczema: treatment strategies Journal of the European Academy of Dermatology and Venereology ·Michael J. Cork	1996	1

About Michael J. Cork

Michael J. Cork is a scholar working on Dermatology, Immunology and Allergy, Speech and Hearing, Pharmaceutical Science and Physiology, having authored 211 papers that have together received 8.6k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (159 papers), Allergic Rhinitis and Sensitization (78 papers), Asthma and respiratory diseases (48 papers), Food Allergy and Anaphylaxis Research (30 papers), Contact Dermatitis and Allergies (27 papers), Urticaria and Related Conditions (23 papers), Neonatal skin health care (23 papers) and Advancements in Transdermal Drug Delivery (21 papers). The work is most often cited by research in Dermatology (5.7k citations), Immunology and Allergy (3.6k citations), Pharmaceutical Science (633 citations), Speech and Hearing (629 citations) and Immunology (1.6k citations). Michael J. Cork has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Simon G. Danby, Ulrich R. Hengge, Thomas Ruzicka, Robert A. Schwartz, Rachid Tazi‐Ahnini, Gordon W. Duff, Yiannis Vasilopoulos, A.J.G. McDonagh, Simon Ward and James Mason. Their work appears in journals such as British Journal of Dermatology, Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, Journal of Dermatological Treatment and Journal of the European Academy of Dermatology and Venereology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact